Editorial: Reframing Risk: Antidepressant Use in Pregnancy and Offspring Mental Health
Journal of the American Academy of Child & Adolescent Psychiatry · 2026-03 · 65 (3) · 346-348
DOI: 10.1016/j.jaac.2025.06.008 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the American Academy of Child & Adolescent Psychiatry, 2026-03. Verfasst von Misty C Richards. Beteiligte Einrichtung: UCLA, Los Angeles, California. Electronic address: mcrichards@mednet.ucla.edu. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Pregnancy Complications, Antidepressive Agents, Selective Serotonin Reuptake Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UCLA, Los Angeles, California. Electronic address: mcrichards@mednet.ucla.edu.
Zitieren
APA
Richards, M. C. (2026). Editorial: Reframing Risk: Antidepressant Use in Pregnancy and Offspring Mental Health. Journal of the American Academy of Child & Adolescent Psychiatry, 65(3), 346-348. https://doi.org/10.1016/j.jaac.2025.06.008
Vancouver
Richards MC. Editorial: Reframing Risk: Antidepressant Use in Pregnancy and Offspring Mental Health. Journal of the American Academy of Child & Adolescent Psychiatry. 2026;65(3):346-348. doi:10.1016/j.jaac.2025.06.008
BibTeX
@article{Richards2026,
author = {Richards, Misty C},
title = {Editorial: Reframing Risk: Antidepressant Use in Pregnancy and Offspring Mental Health},
journal = {Journal of the American Academy of Child & Adolescent Psychiatry},
year = {2026},
volume = {65},
number = {3},
pages = {346--348},
doi = {10.1016/j.jaac.2025.06.008}
}
EUVIMED